Product Class: Oral Anabolic-Androgenic Steroid (AAS)
Active Ingredient: Methandienone (Methandrostenolone)
Concentration: 20 mg/tab or 50 mg/tab
Price For: 100 tablets
Brand: Dianabol
Dianabol 20 / 50 by Zyvex Pharmaceuticals contains Methandienone, also known as Methandrostenolone, in strengths of 20 mg or 50 mg per tablet. Each pack contains 100 tablets. Dianabol is an orally active anabolic-androgenic steroid (AAS) derived from testosterone and historically became one of the best-known oral anabolic steroids.
Methandienone is structurally modified to permit oral activity. Its 17-alpha-alkylated structure reduces rapid hepatic inactivation, but this same characteristic contributes to clinically important liver-related risk. The compound has both anabolic and androgenic activity and can also produce estrogenic effects.
Dianabol has historical pharmaceutical associations with anabolic treatment, but it is not a routine contemporary therapy for muscle building, testosterone deficiency, or athletic performance. Its modern reputation is predominantly associated with non-medical bodybuilding use for rapid increases in body mass and strength.
The 20 mg and 50 mg figures represent tablet strengths. They should not be interpreted as recommended daily doses or performance-enhancement protocols. In particular, a 50 mg tablet represents five times the stated Methandienone content of a 20 mg tablet and should not be treated as a standard individual dose simply because that tablet strength is available.
Methandienone was historically developed as an orally active anabolic steroid and was previously used in selected medical settings where anabolic support was considered desirable. Its therapeutic importance has declined substantially, and it is not a standard modern treatment for male hypogonadism or routine hormone replacement.
For medically confirmed testosterone deficiency, established testosterone formulations are pharmacologically more appropriate because testosterone replacement aims to reproduce physiological testosterone activity rather than provide a non-physiological oral anabolic steroid.
Dianabol is widely associated with bodybuilding and strength sports. In non-medical performance settings, it is commonly discussed in relation to:
Part of the rapid increase in body weight associated with Methandienone can reflect glycogen, intracellular fluid, and estrogen-related water retention rather than newly formed contractile muscle alone.
These uses are non-medical. Methandienone is also prohibited in drug-tested competitive sport.
Methandienone enters cells and binds intracellular androgen receptors. The activated receptor complex influences transcription of androgen-responsive genes, contributing to anabolic and androgenic effects in multiple tissues.
Androgen receptor activity can influence:
Unlike DHT-derived compounds such as Drostanolone or Methenolone, Methandienone can undergo aromatization. Estrogenic metabolites can therefore contribute to fluid retention, breast-tissue stimulation in susceptible men, and other estrogen-associated effects.
Exogenous Methandienone also suppresses hypothalamic-pituitary-gonadal signaling. Reduced LH and FSH can lower endogenous testosterone production and impair spermatogenesis.
Pharmacological and historical performance-related effects associated with Methandienone include:
The rapid scale-weight increase traditionally associated with Dianabol should not be interpreted as pure skeletal-muscle gain. Estrogen-mediated fluid retention and increased glycogen storage can contribute substantially.
These anabolic effects also need to be considered alongside hepatic, cardiovascular, endocrine, reproductive, and androgenic risks.
Dianabol is frequently discussed alongside injectable anabolic steroids in bodybuilding. These combinations are not medically validated treatment protocols and can increase cumulative cardiovascular, endocrine, hepatic, and reproductive risk.
Because Methandienone can produce estrogenic activity, aromatase inhibitors such as Anastrozole or Exemestane are sometimes discussed in performance settings. They should not be used automatically or prophylactically without a clinical indication. Excessive estrogen suppression can negatively affect lipids, bone, sexual function, mood, and general well-being.
Combining Dianabol with other 17-alpha-alkylated oral anabolic steroids can increase hepatic and lipid-related burden and should not be interpreted as a clinically validated strategy.
Dianabol is not conventional Testosterone Replacement Therapy (TRT). Methandienone activates androgen receptors but does not reproduce the complete physiological endocrine profile of testosterone.
TRT is intended to restore testosterone concentrations in appropriately diagnosed hypogonadal patients using established testosterone formulations. Methandienone is an orally modified anabolic steroid and is not an appropriate substitute for Testosterone Enanthate, Testosterone Cypionate, or other recognized testosterone-replacement preparations.
Methandienone can suppress LH and FSH, reducing endogenous testosterone production, intratesticular testosterone, and sperm production. Consequently, non-medical use can result in endocrine suppression rather than restoration of normal testosterone physiology.
There is no medically validated contemporary bodybuilding dose or cycle for Dianabol. Performance regimens circulated through bodybuilding communities should not be interpreted as safe clinical dosing recommendations.
The available strengths described for this product are:
The 50 mg tablet contains five times as much active substance as the 20 mg tablet. This difference represents concentration per tablet and does not establish that 50 mg is an appropriate single or daily dose.
Because Methandienone is a 17-alpha-alkylated oral anabolic steroid, exposure is particularly relevant to hepatic and metabolic safety. Increasing exposure can increase the probability and severity of adverse effects rather than simply increasing anabolic benefit.
There is no medically validated bodybuilding loading phase, dose-escalation ladder, cycle duration, stacking dose, or post-cycle regimen that can be inferred from these tablet strengths.
Methandienone has substantial androgenic activity and presents a significant virilization risk in women.
Potential androgenic effects include:
Some virilizing changes, particularly voice deepening and clitoral enlargement, may be irreversible even after exposure ends.
Neither the 20 mg nor 50 mg tablet strength should be interpreted as an appropriate female performance dose. Methandienone should also be avoided during pregnancy because androgen exposure can interfere with fetal development.
Dianabol 20 / 50 by Zyvex Pharmaceuticals contains Methandienone at 20 mg or 50 mg per tablet, supplied in packs of 100 tablets. Methandienone is a testosterone-derived, orally active 17-alpha-alkylated anabolic-androgenic steroid historically associated with pharmaceutical anabolic therapy and now predominantly encountered in bodybuilding.
Its pharmacological profile includes strong anabolic activity, androgen receptor activation, endocrine suppression, and the potential for estrogenic effects. The oral 17-alpha-alkylated structure also makes hepatic and metabolic safety particularly important. The 20 mg and 50 mg designations describe tablet strength only and do not establish medically validated bodybuilding doses or cycles.
Dianabol is a brand name associated with Methandienone, also called Methandrostenolone. It is an orally active anabolic-androgenic steroid originally developed for pharmaceutical use and now primarily encountered in non-medical bodybuilding contexts.
Methandienone has historical anabolic pharmaceutical use. Today, it is primarily associated with non-medical bodybuilding for rapid increases in body mass and strength rather than a routine modern therapeutic indication.
Methandienone activates androgen receptors and promotes anabolic processes including protein synthesis and nitrogen retention. However, rapid increases in body weight can also include glycogen and fluid rather than muscle tissue alone.
Methandienone can undergo aromatization and produce estrogenic activity. This contributes to its tendency toward fluid retention and other estrogen-associated effects.
Yes. Exogenous anabolic steroids such as Methandienone can suppress LH and FSH signaling, reducing endogenous testosterone production and potentially impairing sperm production.
Please log in to write Dianabol review.